Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer with CNS Metastases
NCT03417544Phase 2Completed
- Sponsor
- Nancy Lin
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in breast cancer, Central Nervous System Metastasis (CNSM), sponsored by Nancy Lin. Started May 2018; status: completed.
02
Drugs
atezolizumab
03
Conditions
breast cancerCentral Nervous System Metastasis (CNSM)
Beyond the preview
Go deeper on NCT03417544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03417544.